UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report: February 15, 2008
(Date of earliest event reported)

LESCARDEN INC.
(Exact name of registrant as specified in its charter)

NEW YORK

000-10035

13-2538207

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

420 Lexington Avenue  

Suite 212

New York, NY

10170

(Address of Principal Executive Offices) (Zip Code)

(212) 687-1050
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below ) :

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01     Entry into a Material Definitive Agreement.

On February 15, 2008, Lescarden Inc. ("Lescarden") entered into an agreement with NanoASIA Company Limited of Bangkok, Thailand ("NanoAsia") granting NanoAsia a 10 year exclusive license to market Lescarden’s proprietary product, CATRIX® WOUND DRESSING in Thailand and Malaysia. A press release announcing the transaction is filed herewith as Exhibit 99.1

Item 9.01     Financial Statements and Exhibits.

(d) Exhibits.

99.1 Copy of Press Release.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   

LESCARDEN INC.

 

 

February 22, 2008

By:

/s/ William E. Luther

William E. Luther

President and Chief Executive Officer

Lescarden (CE) (USOTC:LCAR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Lescarden (CE).
Lescarden (CE) (USOTC:LCAR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Lescarden (CE).